Document is current
Any future updates will be listed below
-
Authors
Kawasaki, Aya
Yamashita, Keita
Hirano, Fumio
Sada, Ken-ei
Tsukui, Daisuke
Kondo, Yuya
Kimura, Yoshitaka
Asako, Kurumi
Kobayashi, Shigeto
Yamada, Hidehiro
Furukawa, Hiroshi https://orcid.org/0000-0002-4022-0767
Nagasaka, Kenji
Sugihara, Takahiko
Yamagata, Kunihiro
Sumida, Takayuki
Tohma, Shigeto
Kono, Hajime
Ozaki, Shoichi
Matsuo, Seiichi
Hashimoto, Hiroshi
Makino, Hirofumi
Arimura, Yoshihiro
Harigai, Masayoshi
Tsuchiya, Naoyuki https://orcid.org/0000-0002-6776-5580
- License Information
-
More Information
Article History
Received: 18 July 2017
Revised: 10 August 2017
Accepted: 22 August 2017
First Online: 5 October 2017
Compliance with ethical standards
:
: FH is employed by the Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University (TMDU), which has received unrestricted research grants from Chugai Pharmaceutical Co., Ltd., Ono Pharmaceuticals, Mitsubishi Tanabe Pharma Co., UCB Japan, CSL Behring, Towa Pharmaceutical Co., Ltd., Abbvie Japan Co., Ltd., Japan Blood Products Organization, Ayumi Pharmaceutical Co., and Nippon Kayaku Co., Ltd. TS received honoraria for lectures from Mitsubishi Tanabe Pharma Co., Ltd., and research grants from Mitsubishi Tanabe Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd., Astellas Pharma Co., Ltd., and Ono Pharmaceutical Co., Ltd. ST received honoraria for lectures from Pfizer, and a research grant from Chugai Pharmaceutical Co., Ltd. HM serves as a consultant for Abbvie Japan Co., Ltd. and Teijin Pharma Ltd. MH has received a research grant from Abbvie. Tokyo Women’s Medical University (TWMU), particularly the Division of Epidemiology and Pharmacoepidemiology in Rheumatic Diseases, has received unrestricted research grants from Ayumi Pharmaceutical Co., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Nippon Kayaku Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., and Teijin Pharma Ltd., with which TWMU paid the salary of MH. NT received 2017 Novartis—Japan Rheumatism Foundation Rheumatology Prize. The remaining authors declare no conflict of interest.
